Combination effect of doxorubicin and HIF inhibitor on MCF-7 CD44+/CD24- subpopulation cells in hypoxic condition
Abstract Hypoxia-inducible factors (HIFs) and cancer stem cells (CSCs) are two challenging causes of radiotherapy and chemotherapy resistance, leading to most cases of failure and recurrence in breast cancer therapy. This study was conducted to investigated the inhibitory effect of combination thera...
Saved in:
Main Authors: | Azadeh Rasouli (Author), Shima Aliebrahimi (Author), Vahideh Montazeri (Author), Mohammad Hossein Ghahremani (Author), Seyed Nasser Ostad (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differential expression of HIF-1α in CD44<sup>+</sup>CD24<sup>-/low </sup>breast ductal carcinomas
by: Soares Fernando A, et al.
Published: (2011) -
Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44+/CD24-/low): an in vitro study
by: Ahmadipour F, et al.
Published: (2015) -
HER2-expressing breast tumors are associated with breast cancer stem-cell phenotype CD44+/CD24-
by: Iris Rabinovich, et al.
Published: (2018) -
CD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma
by: Pouyan Amini Shakib, et al.
Published: (2015) -
Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
by: Gul-, et al.
Published: (2021)